Senior Lecturer in Cardiovascular Science, The University of Bristol

Incorporating Work With Both - Bristol Heart Institute & University Of Bristol

Official Social Media Platform Links for the University Hospital Bristol & Weston NHS Foundation Trust

Official Social Media Platform Links for the University of Bristol
- Top 10 UK university and 54th in the world (QS Rankings 2025)
- Top 5 UK university for research (THE analysis of REF 2021)
- Top 5 most targeted university by top UK employers (High Fliers 2024)
An Introduction To Dr Stephen C Harmer
Dr Stephen Harmer:
Biography
Steve Harmer graduated with a first-class BSc (Hons) in Molecular Biology from the University of Reading. He then undertook a PhD in Molecular Endocrinology at the University of Reading in the laboratory of Professor Philip Lowry.
After his PhD training, Steve joined Professor Andrew Tinker’s group at University College London to pursue post- doctoral research investigating the disease mechanisms underlying inherited cardiac arrhythmias (abnormal heart rhythms).
In October 2011, he moved to the William Harvey Research Institute at Queen Mary University of London. During this period his work established that mutations in potassium ion channels, which cause the Long QT Syndrome, act in the majority of cases to cause defects in ion channel trafficking.
In January 2013, he was awarded an Intermediate Basic Science Research Fellowship from the British Heart Foundation. In April 2018, Steve joined the University of Bristol as a Lecturer in Cardiovascular Science in the School of Physiology, Pharmacology and Neuroscience and in April 2021 was promoted to Senior Lecturer. Steve teaches cardiovascular science-related topics to Veterinary, Medicine, Physiology, Pharmacology and Biomedical Science students.
He also leads an active externally funded research team that focuses on understanding the causes of arrhythmias and developing therapeutic approaches to prevent sudden death in patients with inherited heart conditions.
Dr Stephen C Harmer Working With Donate For Defib W-s-M Project
A welcome from Project Lead, Josh Bell in an official quote:

Dr Stephen Harmer - Speaking At The Donate For Defib Conference - 08.02.25

Presentation By: Dr Stephen C Harmer
Bristol Heart Festival
Donate For Defib W-s-M Project is truly delighted to be supporting the Bristol Heart Festival on Thursday, 13th March 2025!
To find out more about the line up of the day, read and click below!




Summary of Research Interests - Dr Stephen C Harmer
Sudden death due to cardiac causes (SCD) is a major clinical problem and the Long QT Syndrome (LQTS) is an important cause of SCD in young people. LQTS is characterised by a prolongation of the QT interval as visualised on an electrocardiogram (ECG). Thisprolongation can lead to the development of torsade-de-pointes, a characteristic irregular wave pattern on the ECG, and in turn ventricular fibrillation.
LQTS can be an inherited syndrome or acquired, usually as a result of drug therapy. Of the hereditary forms of LQTS approximately half of all cases are associated with mutations in KCNQ1 or KCNE1. These two proteins assemble to form a heteromultimeric channel complex, composed of a
tetramer of KCNQ1 α-subunits and between one and four KCNE1 β-subunits, which produces a potassium current in ventricular myocytes called I Ks .
The I Ks current is critical for repolarisation of the human cardiac action potential and mutations in either of these ion channel subunits can cause LQTS. In detail, mutations in KCNQ1 underlie LQTS type 1 (LQTS1) whilst mutations in KCNE1 account for LQTS5. Recently it has become clear that, in addition to their effects on channel function, mutations in either KCNQ1 or KCNE1 can act to disrupt the trafficking of the channel complex to its site of action at the cell surface.
Dr Steve Harmer’s research focusses on characterising the molecular mechanisms that underlie ion channel trafficking and why mutated channels become defectively trafficked.
His research interests include:
- Characterisation of the molecular mechanisms that underlie defective ion channel trafficking in the LQTS.
- Using inducible pluripotent stem cell (iPSc) technology to generate cardiac cells from patients with arrhythmic syndromes (including LQTS) that can be used as model systems in which to study disease mechanisms.
- The development of therapeutic strategies that can rescue the function of disease causing LQTS1 mutations with the aim of preventing sudden death in these patients.
Available Resources
University of Bristol -
Official Address:
The University of Bristol,
Faculty of Health & Life Sciences, School of Physiology, Pharmacology and Neuroscience,
Biomedical Sciences Building, Office DW2B,
University Walk,
Bristol, BS8 1TD.
Enquiries & Contacting Dr Stephen C Harmer
To contact Dr Stephen Harmer with any questions or information, please email: s.c.harmer@bristol.ac.uk
Also, feel free to complete our ‘Contact Us’ Form below that will be directly sent to Dr Stephen Harmer